Calcium Trisodium Pentetate (Ca-DTPA) ampoules

Scope Summary

The Department of National Defence (DND), through the Strategic Medical Countermeasures Program (SMCP) on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp), has a requirement for the supply of Calcium Trisodium Pentetate (Ca-DTPA) ampoules for the treatment of Canadian Armed Forces (CAF) personnel who may have been exposed to radioactive contamination involving transuranic elements. The Ca-DTPA product must consist of sterile Calcium Trisodium Pentetate solution for injection, containing approximately 1,000 mg to 1,055 mg of active ingredient in a 5 mL ampoule suitable for intravenous administration. The product is intended for use as a medical countermeasure to enhance the elimination of internally deposited radioactive transuranic elements, including plutonium, americium and curium, following confirmed or suspected radiological exposure. The product must meet all applicable regulatory, quality assurance, packaging, labelling and shelf-life requirements specified in the solicitation documents. The initial requirement consists of the supply of 250 Ca-DTPA ampoules for delivery no later than 1 March 2027. The resulting contract is anti

Bid Readiness Checklist

• 1. Portal Registration & Eligibility Mandatory
  Confirm active supplier account on the issuing portal to submit bids to buyer "Department of National Defence (DND)" (Canada).
  Suggested Evidence: SAP Ariba Supplier ID / Procurement Business Number (PBN)
• 2. Submission Deadline & Format Mandatory
  Finalize pricing and compliance attachments at least 24 hours ahead of Closes 2026-11-25 · 11 days left.
  Suggested Evidence: Signed Cover Form, Mandatory Returnables & Complete File Upload
• 3. Clinical / Research Governance Mandatory
  Confirm regulatory compliance, privacy/confidentiality safeguards, and qualifications of lead specialists.
  Suggested Evidence: Credentials, Governance Policy & Ethics Compliance
• 4. Commercial Pricing Schedule Mandatory
  Structure transparent itemized fixed or T&M rate pricing aligned with notice deliverables (ceiling not disclosed in notice).
  Suggested Evidence: Itemized Pricing Table, Rate Card & Scope Assumptions